Completed
Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer
NCT00984282
- Conditions
- Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +4 more
- Locations
-
- Los Angeles, California, United States
- Stanford, California, United States
- New Haven, Connecticut, United States
- Atlanta, Georgia, United States